It is very uncertain whether sulodexide + local treatment changes proportion of ulcers completely healed at 30 days compared with local treatment (very low certainty).

3 findings from 1 review

Sulodexide for treating venous leg ulcers 2016 · Cochrane Headline outcomes only
RR 1.91 [1, 3.66]
1 study · 114 participants
Very low
Sulodexide for treating venous leg ulcers 2016 · Cochrane Headline outcomes only
RR 1.65 [1.2, 2.28]
2 studies · 324 participants
Low
Sulodexide for treating venous leg ulcers 2016 · Cochrane Headline outcomes only
RR 1.6 [1.17, 2.2]
1 study · 230 participants
Low

Nitroglycerin vs no treatment

All‐cause mortality in 30 days post operation · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia

It is very uncertain whether nitroglycerin changes all‐cause mortality in 30 days post operation compared with no treatment (very low certainty).

1 finding from 1 review

Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non‐cardiac surgery 2016 · Cochrane Headline outcomes only
RR 0.33 [0.01, 7.87]
1 study · 60 participants
Very low

Nitroglycerin vs placebo

All‐cause mortality in 30 days post operation · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia

It is very uncertain whether nitroglycerin changes all‐cause mortality in 30 days post operation compared with placebo (very low certainty).

1 finding from 1 review

Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non‐cardiac surgery 2016 · Cochrane Headline outcomes only
RR 2.81 [0.12, 63.83]
2 studies · 89 participants
Very low

Ankle brace vs rigid cast

Return to activity · children with acute 'low risk' (undisplaced) ankle fractures

1 finding from 1 review

Interventions for treating ankle fractures in children 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low

Intervention not reported

Number of days on which bleeding occurred ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation

The review found no eligible studies for this question.

1 finding from 1 review

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies… 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Thrombopoietin mimetics vs placebo or usual care

Number of days on which bleeding occurred ‐ not measured · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation

The review found no eligible studies for this question.

1 finding from 1 review

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies… 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Caregiver‐mediated exercises vs control intervention

Length of stay: length of stay in rehabilitation unit in days · people with stroke

1 finding from 1 review

Caregiver‐mediated exercises for improving outcomes after stroke 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Sterile water vs 0.05% chlorohexidine gluconate

Symptomatic CAUTI at 14 days after replacement · adults with replacing long‐term indwelling urinary catheters

1 finding from 1 review

Policies for replacing long‐term indwelling urinary catheters in adults 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 16 participants
Very low

Subcutaneous insulin lispro vs intravenous regular insulin

All‐cause mortality (N) Mean hospital stay: 2‐7 days

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 156 participants
Moderate

Subcutaneous insulin aspart vs intravenous regular insulin

Time to resolution of diabetic ketoacidosis (h) Mean hospital stay: 3‐5 days

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Subcutaneous insulin aspart vs intravenous regular insulin

Length of hospital stay

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Low

Subcutaneous insulin lispro vs intravenous regular insulin

Hypoglycaemic episodes

Subcutaneous insulin lispro showed no clear difference in hypoglycaemic episodes (N) Mean hospital stay: 2‐7 days compared with intravenous regular insulin (low certainty).

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
RR 0.59 [0.23, 1.52]
4 studies · 156 participants
Low

Subcutaneous insulin lispro vs intravenous regular insulin

Length of hospital stay

2 findings from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 96 participants
GRADE not reported
Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 90 participants
Low

Subcutaneous insulin lispro vs intravenous regular insulin

Time to resolution of diabetic ketoacidosis (h) Mean hospital stay: 2‐4 days

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 90 participants
Very low

Subcutaneous insulin aspart vs intravenous regular insulin

All‐cause mortality (N) Mean hospital stay: 2‐7 days

1 finding from 1 review

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 45 participants
Low